40 related articles for article (PubMed ID: 23997002)
1. Immunogenicity and safety of the human papillomavirus vaccine in patients with autoimmune diseases: A systematic review.
Pellegrino P; Radice S; Clementi E
Vaccine; 2015 Jul; 33(30):3444-9. PubMed ID: 26036945
[TBL] [Abstract][Full Text] [Related]
2. Human Papilloma Virus Vaccination in Patients with Rheumatic Diseases in France: A Study of Vaccination Coverage and Drivers of Vaccination.
David E; Roy P; Belot A; Quartier P; Bader Meunier B; Aeschlimann FA; Lega JC; Durieu I; Rousset-Jablonski C
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887899
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment - a systematic review.
Keller M; Pittet LF; Zimmermann P
Eur J Pediatr; 2022 Apr; 181(4):1329-1362. PubMed ID: 34936010
[TBL] [Abstract][Full Text] [Related]
4. Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical Guide.
Blanchard-Rohner G
Front Immunol; 2021; 12():711637. PubMed ID: 34408752
[TBL] [Abstract][Full Text] [Related]
5. The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study.
Kostik MM; Lubimova NA; Fridman IV; Goleva OV; Kharit SM
Pediatr Rheumatol Online J; 2021 Jul; 19(1):108. PubMed ID: 34225748
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study.
Grein IHR; Pinto NBF; Groot N; Martins CB; Lobo A; Aikawa NE; Barbosa C; Terreri MT; da Fraga ACM; de Oliveira SKF; Sztajnbok F; Paim Marques LB; Islabão AG; Appenzeller S; Bica B; de Oliveira Sato J; Magalhães CS; Ferriani V; Pasmans H; Schepp R; van der Klis F; de Roock S; Wulffraat N; Pileggi GS
Pediatr Rheumatol Online J; 2020 Nov; 18(1):87. PubMed ID: 33176806
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016.
Martínez-Gómez X; Curran A; Campins M; Alemany L; Rodrigo-Pendás JÁ; Borruel N; Castellsagué X; Díaz-de-Heredia C; Moraga-Llop FA; Del Pino M; Torné A
Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782268
[TBL] [Abstract][Full Text] [Related]
8. Recommendations and barriers to vaccination in systemic lupus erythematosus.
Garg M; Mufti N; Palmore TN; Hasni SA
Autoimmun Rev; 2018 Oct; 17(10):990-1001. PubMed ID: 30103044
[TBL] [Abstract][Full Text] [Related]
9. The effect of history of abnormal pap smear or preceding HPV infection on the humoral immune response to Quadrivalent Human Papilloma virus (qHPV) vaccine in women with systemic lupus erythematosus.
Dhar JP; Essenmacher L; Dhar R; Magee A; Ager J; Sokol RJ
Hum Vaccin Immunother; 2018; 14(9):2318-2322. PubMed ID: 29708835
[TBL] [Abstract][Full Text] [Related]
10. A review on SLE and malignancy.
Choi MY; Flood K; Bernatsky S; Ramsey-Goldman R; Clarke AE
Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):373-396. PubMed ID: 29224679
[TBL] [Abstract][Full Text] [Related]
11. HPV infection and vaccination in Systemic Lupus Erythematosus patients: what we really should know.
Grein IH; Groot N; Lacerda MI; Wulffraat N; Pileggi G
Pediatr Rheumatol Online J; 2016 Mar; 14(1):12. PubMed ID: 26956735
[TBL] [Abstract][Full Text] [Related]
12. Vaccinations in paediatric rheumatology: an update on current developments.
Groot N; Heijstek MW; Wulffraat NM
Curr Rheumatol Rep; 2015 Jul; 17(7):46. PubMed ID: 26025339
[TBL] [Abstract][Full Text] [Related]
13. Vaccination in paediatric rheumatology.
Akikusa JD; Crawford NW
Curr Rheumatol Rep; 2014 Aug; 16(8):432. PubMed ID: 24925588
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of the bivalent human papillomavirus vaccine in adolescents with juvenile systemic lupus erythematosus or juvenile dermatomyositis.
Heijstek MW; Scherpenisse M; Groot N; Wulffraat NM; Van Der Klis FR
J Rheumatol; 2013 Sep; 40(9):1626-7. PubMed ID: 23997002
[No Abstract] [Full Text] [Related]
15. Human papillomavirus vaccine in patients with systemic lupus erythematosus.
Pellegrino P; Carnovale C; Perrone V; Salvati D; Gentili M; Antoniazzi S; Clementi E; Radice S
Epidemiology; 2014 Jan; 25(1):155-6. PubMed ID: 24296931
[No Abstract] [Full Text] [Related]
16. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study.
Mok CC; Ho LY; Fong LS; To CH
Ann Rheum Dis; 2013 May; 72(5):659-64. PubMed ID: 22589375
[TBL] [Abstract][Full Text] [Related]
17. [Juvenile dermatomyositis. Immunologic and clinical overlapping with systemic lupus erythematosus].
Wollina U; Roth H; Grübner I
Dermatol Monatsschr; 1985; 171(10):634-40. PubMed ID: 3877649
[No Abstract] [Full Text] [Related]
18. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States.
Grant LA; Dunne EF; Chesson H; Markowitz LE
Vaccine; 2011 Mar; 29(13):2365-70. PubMed ID: 21277406
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
